Kyverna Therapeutics, Inc.KYTXNASDAQ
Loading
Operating Cash Flow Growth Under PressureDecelerating
Percentile Rank0
Studio
Year-over-Year Change

Year-over-year operating cash flow growth rate

Latest
-117.99%
↓ 109% vs avg
Percentile
P0
Near historical low
Streak
1 yr
Consecutive declineDecelerating
Average
-56.53%
Historical baseline
PeriodValue
2024-117.99%
2023-45.13%
2022-63.00%
20210.00%